The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.
New psychoactive substances: a review and updates
Open accessAbstract
New psychoactive substances (NPS) are a heterogeneous group of substances. They are associated with a number of health and social harms on an individual and societal level. NPS toxicity and dependence syndromes are recognised in primary care, emergency departments, psychiatric inpatient and community care settings. One pragmatic classification system is to divide NPS into one of four groups: synthetic stimulants, synthetic cannabinoids, synthetic hallucinogens and synthetic depressants (which include synthetic opioids and benzodiazepines). We review these four classes of NPS, including their chemical structures, mechanism of action, modes of use, intended intoxicant effects, and their associated physical and mental health harms. The current challenges faced by laboratory testing for NPS are also explored, in the context of the diverse range of NPS currently available, rate of production and emergence of new substances, the different formulations, and methods of acquisition and distribution.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review
Armenian, P., Vo, K. T., Barr-Walker, J., & Lynch, K. L. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.10.016 · Cited by 710
The Toxicology of Bath Salts: A Review of Synthetic Cathinones
Prosser, J. M., & Nelson, L. S. (2012) · Journal of Medical Toxicology · doi:10.1007/s13181-011-0193-z · Cited by 705
A review: Fentanyl and non-pharmaceutical fentanyls
Suzuki, J., & El-Haddad, S. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.11.033 · Cited by 445
Baumann, M. H., Ayestas, M. A., Partilla, J. S., Sink, J. R., Shulgin, A. T., Daley, P. F., Brandt, S. D., Rothman, R. B., Ruoho, A. E., & Cozzi, N. V. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.304 · Cited by 439
Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly
Pacher, P., Steffens, S., Haskó, G., Schindler, T. H., & Kunos, G. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.130 · Cited by 439
Ketamine: 50 Years of Modulating the Mind
Li, L., & Vlisides, P. E. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00612 · Cited by 385
Tait, R. J., Caldicott, D., Mountain, D., Hill, S. L., & Lenton, S. (2016) · Clinical Toxicology · doi:10.3109/15563650.2015.1110590 · Cited by 378
New psychoactive substances: challenges for drug surveillance, control, and public health responses
Peacock, A., Bruno, R., Gisev, N., Degenhardt, L., Hall, W., Sedefov, R., White, J., Thomas, K. V., Farrell, M., & Griffiths, P. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32231-7 · Cited by 360
Bath salts and synthetic cathinones: An emerging designer drug phenomenon
German, C. L., Fleckenstein, A. E., & Hanson, G. R. (2014) · Life Sciences · doi:10.1016/j.lfs.2013.07.023 · Cited by 348
Khat and synthetic cathinones: a review
Valente, M. J., Guedes de Pinho, P., de Lourdes Bastos, M., Carvalho, F., & Carvalho, M. (2014) · Archives of Toxicology · doi:10.1007/s00204-013-1163-9 · Cited by 337
Winstock, A. R., & Barratt, M. J. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.12.011 · Cited by 331
Peiper, N. C., Clarke, S. D., Vincent, L. B., Ciccarone, D., Kral, A. H., & Zibbell, J. E. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2018.08.007 · Cited by 317
Murray, R. M., Quigley, H., Quattrone, D., Englund, A., & Di Forti, M. (2016) · World Psychiatry · doi:10.1002/wps.20341 · Cited by 315
A survey study to characterize use of Spice products (synthetic cannabinoids)
Vandrey, R., Dunn, K. E., Fry, J. A., & Girling, E. R. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.07.011 · Cited by 283
Designer drugs: mechanism of action and adverse effects
Luethi, D., & Liechti, M. E. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02693-7 · Cited by 262
Fantegrossi, W. E., Moran, J. H., Radominska-Pandya, A., & Prather, P. L. (2014) · Life Sciences · doi:10.1016/j.lfs.2013.09.017 · Cited by 261
Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal
Cooper, Z. D. (2016) · Current Psychiatry Reports · doi:10.1007/s11920-016-0694-1 · Cited by 253
LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality
Dolder, P. C., Schmid, Y., Müller, F., Borgwardt, S., & Liechti, M. E. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.82 · Cited by 247
Synthetic Cathinones: A New Public Health Problem
Karila, L., Megarbane, B., Cottencin, O., & Lejoyeux, M. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666141210224137 · Cited by 245
From PCP to MXE: a comprehensive review of the non‐medical use of dissociative drugs
Morris, H., & Wallach, J. (2014) · Drug Testing and Analysis · doi:10.1002/dta.1620 · Cited by 244
Coppola, M., & Mondola, R. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.03.009 · Cited by 239
Banister, S. D., Moir, M., Stuart, J., Kevin, R. C., Wood, K. E., Longworth, M., Wilkinson, S. M., Beinat, C., Buchanan, A. S., Glass, M., et al. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00112 · Cited by 234
Substituted methcathinones differ in transporter and receptor interactions
Eshleman, A. J., Wolfrum, K. M., Hatfield, M. G., Johnson, R. A., Murphy, K. V., & Janowsky, A. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.04.004 · Cited by 229
Recreational Use, Analysis and Toxicity of Tryptamines
Tittarelli, R., Mannocchi, G., Pantano, F., & Romolo, F. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666141210222409 · Cited by 221
NMDA receptor function, memory, and brain aging
Newcomer, J. W., Farber, N. B., & Olney, J. W. (2000) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2000.2.3/jnewcomer · Cited by 220
Uthaug, M. V., van Oorsouw, K., Kuypers, K. P. C., van Boxtel, M., Broers, N. J., Mason, N. L., Toennes, S. W., Riba, J., & Ramaekers, J. G. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4988-3 · Cited by 212
Psychoactive “bath salts”: Not so soothing
Baumann, M. H., Partilla, J. S., & Lehner, K. R. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.11.020 · Cited by 208
Differences between opioids: pharmacological, experimental, clinical and economical perspectives
Drewes, A. M., Jensen, R. D., Nielsen, L. M., Droney, J., Christrup, L. L., Arendt‐Nielsen, L., Riley, J., & Dahan, A. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04317.x · Cited by 208
2C or Not 2C: Phenethylamine Designer Drug Review
Dean, B. V., Stellpflug, S. J., Burnett, A. M., & Engebretsen, K. M. (2013) · Journal of Medical Toxicology · doi:10.1007/s13181-013-0295-x · Cited by 204
Banister, S. D., Stuart, J., Kevin, R. C., Edington, A., Longworth, M., Wilkinson, S. M., Beinat, C., Buchanan, A. S., Hibbs, D. E., Glass, M., et al. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00107 · Cited by 197
Miliano, C., Serpelloni, G., Rimondo, C., Mereu, M., Marti, M., & De Luca, M. A. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00153 · Cited by 197
Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines
Cozzi, N. V., Sievert, M. K., Shulgin, A. T., Jacob, P., & Ruoho, A. E. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00538-5 · Cited by 194
Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health
Weinstein, A. M., Rosca, P., Fattore, L., & London, E. D. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00156 · Cited by 194
Next generation of novel psychoactive substances on the horizon – A complex problem to face
Zawilska, J. B., & Andrzejczak, D. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.09.030 · Cited by 191
Kratom—Pharmacology, Clinical Implications, and Outlook: A Comprehensive Review
Eastlack, S. C., Cornett, E. M., & Kaye, A. D. (2020) · Pain and Therapy · doi:10.1007/s40122-020-00151-x · Cited by 189
Hoyte, C. O., Jacob, J., Monte, A. A., Al-Jumaan, M., Bronstein, A. C., & Heard, K. J. (2012) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2012.03.007 · Cited by 186
Fattore, L. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.02.001 · Cited by 178
Charbogne, P., Kieffer, B. L., & Befort, K. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.028 · Cited by 176
Focus on cannabinoids and synthetic cannabinoids
Le Boisselier, R., Alexandre, J., Lelong‐Boulouard, V, & Debruyne, D. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.563 · Cited by 169
Synthetic Cathinones (“Bath Salts”)
Banks, M. L., Worst, T. J., Rusyniak, D. E., & Sprague, J. E. (2014) · The Journal of Emergency Medicine · doi:10.1016/j.jemermed.2013.11.104 · Cited by 164
Roth, B. L., Gibbons, S., Arunotayanun, W., Huang, X., Setola, V., Treble, R., & Iversen, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059334 · Cited by 163
The Fentanyl Epidemic and Evolution of Fentanyl Analogs in the United States and the European Union
Jannetto, P. J., Helander, A., Garg, U., Janis, G. C., Goldberger, B., & Ketha, H. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2017.281626 · Cited by 162
Hill, S. L., Doris, T., Gurung, S., Katebe, S., Lomas, A., Dunn, M., Blain, P., & Thomas, S. H. L. (2013) · Clinical Toxicology · doi:10.3109/15563650.2013.802795 · Cited by 158
The emergence of new psychoactive substance (NPS) benzodiazepines: A review
Manchester, K. R., Lomas, E. C., Waters, L. J., Dempsey, F. C., & Maskell, P. (2017) · Drug Testing and Analysis · doi:10.1002/dta.2211 · Cited by 150
Soussan, C., & Kjellgren, A. (2016) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2016.03.007 · Cited by 149
An expanding world of new psychoactive substances—designer benzodiazepines
Zawilska, J. B., & Wojcieszak, J. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.02.015 · Cited by 143
The American Psychiatric Publishing Textbook of Substance Abuse Treatment
Blumenthal, D. M. (2009) · JAMA · doi:10.1001/jama.2009.144 · Cited by 142
Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles
Baumeister, D., Barnes, G. L., Giaroli, G., & Tracy, D. K. (2014) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125314527985 · Cited by 142
Self-citationThe European Drug Emergencies Network (Euro-DEN)
Wood, D. M., Heyerdahl, F., Yates, C., Dines, A. M., Giraudon, I., Hovda, K. E., & Dargan, P. I. (2014) · Clinical Toxicology · doi:10.3109/15563650.2014.898771 · Cited by 140
Self-citationBanister, S. D., & Connor, M. A. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_144 · Cited by 137
Bogenschutz, M. P., Podrebarac, S. K., Duane, J. H., Amegadzie, S. S., Malone, T. C., Owens, L. T., Ross, S., & Mennenga, S. E. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00100 · Cited by 134
Esposito, S., Deventer, K., Dumoulin, M., & Van Eenoo, P. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1418 · Cited by 133
Novel psychoactive substances: types, mechanisms of action, and effects
Tracy, D. K., Wood, D. M., & Baumeister, D. (2017) · BMJ · doi:10.1136/bmj.i6848 · Cited by 133
Self-citationWINSTOCK, A. R., Lynskey, M. T., Borschmann, R., & Waldron, J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115574493 · Cited by 129
Postmortem Toxicology of New Synthetic Opioids
Concheiro, M., Chesser, R., Pardi, J., & Cooper, G. A. A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01210 · Cited by 128
Cathinone: An Investigation of Several N-Alkyl and Methylenedioxy-Substituted Analogs
Cason, T. A. D., Young, R., & Glennon, R. A. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00323-7 · Cited by 125
Mercieca, G., Odoardi, S., Cassar, M., & Rossi, S. S. (2017) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2017.11.024 · Cited by 123
Nielson, E. M., May, D. G., Forcehimes, A. A., & Bogenschutz, M. P. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00132 · Cited by 122
Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine
Wood, D. M., Davies, S., Puchnarewicz, M., Johnston, A. E., & Dargan, P. I. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1199-9 · Cited by 117
Self-citationHelander, A., Bäckberg, M., Signell, P., & Beck, O. (2017) · Clinical Toxicology · doi:10.1080/15563650.2017.1303141 · Cited by 117
Law, R., Schier, J. G., Martin, C. A., Chang, A. S., & Wolkin, A. F. (2015) · PubMed Central · Cited by 116
VDAC1 and the TSPO: Expression, Interactions, and Associated Functions in Health and Disease States
Shoshan‐Barmatz, V., Pittala, S., & Mizrachi, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133348 · Cited by 113
Duffy, B. C., Li, L., Lu, S., Durocher, L. A., Dittmar, M. A., Delaney-Baldwin, E. R., Panawennage, D., LeMaster, D. M., Navarette, K. A., & Spink, D. C. (2020) · Toxics · doi:10.3390/toxics8010008 · Cited by 113
Siddiqi, S., Verney, C., Dargan, P. I., & Wood, D. M. (2014) · Clinical Toxicology · doi:10.3109/15563650.2014.983239 · Cited by 112
Self-citationThe effects of synthetic cannabinoids on executive function
Cohen, K., Kapitány‐Fövény, M., Mama, Y., Arieli, M., Rosca, P., Demetrovics, Z., & Weinstein, A. M. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4546-4 · Cited by 112
dos Santos, R. G., & Hallak, J. E. C. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.12.001 · Cited by 111
Salomone, A., Giulia, G., Corcia, D. D., Gerace, E., & Vincenti, M. (2015) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-015-9247-4 · Cited by 110
Cameron, K. N., Kolanoś, R., Vekariya, R. H., DeFelice, L. J., & Glennon, R. A. (2013) · Psychopharmacology · doi:10.1007/s00213-013-2967-2 · Cited by 109
Banister, S. D., & Connor, M. A. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_143 · Cited by 105
Prevalence of use and acute toxicity associated with the use of NBOMe drugs
Wood, D. M., Sedefov, R., Cunningham, A., & Dargan, P. I. (2015) · Clinical Toxicology · doi:10.3109/15563650.2015.1004179 · Cited by 102
Self-citationTherapeutic use of classic psychedelics to treat cancer-related psychiatric distress
Ross, S. (2018) · International Review of Psychiatry · doi:10.1080/09540261.2018.1482261 · Cited by 102
Butyrfentanyl Overdose Resulting in Diffuse Alveolar Hemorrhage
Cole, J. B., Dunbar, J. F., McIntire, S., Regelmann, W. E., & Slusher, T. M. (2015) · PEDIATRICS · doi:10.1542/peds.2014-2878 · Cited by 100
Fatal intoxication with synthetic cannabinoid MDMB-CHMICA
Adamowicz, P. (2016) · Forensic Science International · doi:10.1016/j.forsciint.2016.02.024 · Cited by 95
Baumann, M. H., Majumdar, S., Le Rouzic, V., Hunkele, A., Uprety, R., Huang, X. P., Xu, J., Roth, B. L., Pan, Y.-X., & Pasternak, G. W. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.08.016 · Cited by 92
Stellpflug, S. J., Kealey, S. E., Hegarty, C. B., & Janis, G. C. (2013) · Journal of Medical Toxicology · doi:10.1007/s13181-013-0314-y · Cited by 91
Designer Benzodiazepines: Another Class of New Psychoactive Substances
Moosmann, B., & Auwärter, V. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_154 · Cited by 91
Rapid and simple LC‐MS/MS screening of 64 novel psychoactive substances using dried blood spots
Ambach, L., Redondo, A. H., König, S., & Weinmann, W. (2013) · Drug Testing and Analysis · doi:10.1002/dta.1505 · Cited by 89
Effect fingerprinting of new psychoactive substances (NPS): What can we learn from in vitro data?
Hondebrink, L., Zwartsen, A., & Westerink, R. H. S. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.10.022 · Cited by 89
Characteristics and circumstances of synthetic cannabinoid-related death
Darke, S. G., Duflou, J. A., Farrell, M., Peacock, A., & Lappin, J. (2019) · Clinical Toxicology · doi:10.1080/15563650.2019.1647344 · Cited by 88
The ADHD Explosion: Myths, Medication, Money, and Today's Push for Performance
Mayes, R. (2015) · Journal of Health Politics Policy and Law · doi:10.1215/03616878-2888627 · Cited by 87
Carpenter, J. E., Murray, B. P., Dunkley, C. A., Kazzi, Z., & Gittinger, M. H. (2018) · Clinical Toxicology · doi:10.1080/15563650.2018.1510502 · Cited by 85
Methoxetamine associated reversible cerebellar toxicity: Three cases with analytical confirmation
Shields, J. E., Dargan, P. I., Wood, D. M., Puchnarewicz, M., Davies, S., & Waring, W. S. (2012) · Clinical Toxicology · doi:10.3109/15563650.2012.683437 · Cited by 84
Self-citationAres-Fuentes, A. M., Fernández, P. F., Regenjo, M., et al. (2017) · Talanta · doi:10.1016/j.talanta.2017.06.022 · Cited by 84
Lawn, W., Hallak, J. E. C., Crippa, J. A. S., SANTOS, R. G. D., Porffy, L., Barratt, M. J., Ferris, J., WINSTOCK, A. R., & Morgan, C. J. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-14700-6 · Cited by 84
Wallach, J. V., Kang, H., Colestock, T., Morris, H., Bortolotto, Z. A., Collingridge, G. L., Lodge, D., Halberstadt, A. L., Brandt, S. D., & Adejare, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157021 · Cited by 83
Boileau, I., Mansouri, E., Williams, B., Le Foll, B., Rusjan, P., Mizrahi, R., Tyndale, R. F., Huestis, M. A., Payer, D. E., Wilson, A. A., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.04.012 · Cited by 82
Fatality Due to Acute α-Methyltryptamine Intoxication
Boland, D. M., Andollo, W., Hime, G. W., & Hearn, W. L. (2005) · Journal of Analytical Toxicology · doi:10.1093/jat/29.5.394 · Cited by 81
Pharmacotoxicology of Non-fentanyl Derived New Synthetic Opioids
Solimini, R., Pichini, S., Pacifici, R., Busardò, F. P., & Giorgetti, R. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00654 · Cited by 81
Delirium Due to Intoxication from the Novel Synthetic Tryptamine 5‐MeO‐ DALT
Jovel, A., Felthous, A. R., & Bhattacharyya, A. (2013) · Journal of Forensic Sciences · doi:10.1111/1556-4029.12367 · Cited by 80
Analytically Confirmed Intoxications Involving MDMB-CHMICA from the STRIDA Project
Bäckberg, M., Tworek, L., Beck, O., & Helander, A. (2016) · Journal of Medical Toxicology · doi:10.1007/s13181-016-0584-2 · Cited by 79
Pathological Findings in 2 Cases of Fatal 25I-NBOMe Toxicity
Walterscheid, J. P., Phillips, G. T., Lopez, A. E., Gonsoulin, M., Chen, H.-H., & Sanchez, L. A. (2014) · American Journal of Forensic Medicine & Pathology · doi:10.1097/paf.0000000000000082 · Cited by 78
Kusano, M., Zaitsu, K., Taki, K., Hisatsune, K., Nakajima, J., Moriyasu, T., Asano, T., Hayashi, Y., Tsuchihashi, H., & Ishii, A. (2017) · Drug Testing and Analysis · doi:10.1002/dta.2215 · Cited by 75
Synthetic cathinones: “A khat and mouse game”
Katz, D. P., Bhattacharya, D., Bhattacharya, S., DeRuiter, J., Clark, C. R., Suppiramaniam, V. D., & Dhanasekaran, M. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.06.020 · Cited by 72
Eshleman, A. J., Wolfrum, K. M., Reed, J. F., Kim, S. O., Johnson, R. A., & Janowsky, A. J. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.09.024 · Cited by 71
5-Methoxy-N,N-Diisopropyltryptamine-Induced Flashbacks
Akifumi, I., SEKIGUCHI, K., Fujita, K.-I., Yamadera, H., & Koga, Y. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.4.815 · Cited by 69
Colón-Pérez, L. M., Tran, K., Thompson, K., Pace, M. C., Blum, K., Goldberger, B. A., Gold, M. S., Bruijnzeel, A. W., Setlow, B., & Febo, M. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.40 · Cited by 68
Ford, L. T., & Berg, J. D. (2018) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563218767462 · Cited by 67
Finlay, D. B., Manning, J. J., Ibsen, M. S., Macdonald, C. E., Patel, M., Javitch, J. A., Banister, S. D., & Glass, M. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00429 · Cited by 67
Chung, H., Choi, H., Heo, S., Kim, E., & Lee, J. (2013) · Forensic Toxicology · doi:10.1007/s11419-013-0213-6 · Cited by 65
Rinaldi, R., Bersani, G., Marinelli, E., & Zaami, S. (2020) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2727 · Cited by 65
The Pharmacologic and Clinical Effects of Illicit Synthetic Cannabinoids
White, C. M. (2016) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.827 · Cited by 63
Armenian, P., Darracq, M. A., Gevorkyan, J., Clark, S., Kaye, B., & Brandehoff, N. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.10.017 · Cited by 63
Determination of Designer Drug Cross-Reactivity on Five Commercial Immunoassay Screening Kits
Regester, L. E., Chmiel, J. D., Holler, J. M., Vorce, S. P., LEVINE, B. S., & Bosy, T. Z. (2014) · Journal of Analytical Toxicology · doi:10.1093/jat/bku133 · Cited by 60
Partridge, E., Trobbiani, S., Stockham, P. C., Charlwood, C., & Kostakis, C. (2018) · Journal of Analytical Toxicology · doi:10.1093/jat/bky039 · Cited by 60
Fatality Following Ingestion of Tetrahydrofuranylfentanyl, U-49900 and Methoxy-Phencyclidine
Krotulski, A. J., Papsun, D. M., Friscia, M., Swartz, J., Holsey, B. D., & Logan, B. K. (2017) · Journal of Analytical Toxicology · doi:10.1093/jat/bkx092 · Cited by 59
Wagmann, L., Richter, L. H. J., Kehl, T., Wack, F., Bergstrand, M. P., Brandt, S. D., Stratford, A., Maurer, H. H., & Meyer, M. R. (2019) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-018-1558-9 · Cited by 58
What are the psychological effects of using synthetic cannabinoids? A systematic review
Akram, H., Mokrysz, C., & Curran, H. V. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119826592 · Cited by 58
Mitragynine concentrations in two fatalities
Domingo, O., Roider, G., Stöver, A., Graw, M., Mußhoff, F., Sachs, H., & Bicker, W. (2016) · Forensic Science International · doi:10.1016/j.forsciint.2016.12.020 · Cited by 57
(2020) · The FASEB Journal · doi:10.1096/fsb2.21134 · Cited by 57
Banister, S. D., Adams, A. J., Kevin, R. C., Macdonald, C. E., Glass, M., Boyd, R. A., Connor, M. A., McGregor, I. S., Havel, C. M., Bright, S. J., et al. (2018) · Drug Testing and Analysis · doi:10.1002/dta.2491 · Cited by 56
Trouiller, P., Velter, A., Saboni, L., Sommen, C., Sauvage, C., Vaux, S., Barin, F., Chevaliez, S., Lot, F., & Jauffret‐Roustide, M. (2020) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2020.102703 · Cited by 56
Waters, L. J., Manchester, K. R., Maskell, P., Haegeman, C., & Haider, S. M. (2017) · Science & Justice · doi:10.1016/j.scijus.2017.12.004 · Cited by 54
Kinetic analysis of the cannabinoid-1 receptor PET tracer [18F]MK-9470 in human brain
Bohorquez, S. M. S., Hamill, T. G., Goffin, K. E., Lepeleire, I. D., Bormans, G. M., Burns, H. D., & Laere, K. V. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1340-5 · Cited by 53
Brandt, S. D., Kavanagh, P., Westphal, F., Stratford, A., Elliott, S., Dowling, G., Wallach, J., & Halberstadt, A. (2019) · Drug Testing and Analysis · doi:10.1002/dta.2613 · Cited by 53
Richeval, C., Gaulier, J., Romeuf, L., Allorge, D., & Gaillard, Y. (2018) · International Journal of Legal Medicine · doi:10.1007/s00414-018-1969-3 · Cited by 51
Teenage Cardiac Arrest Following Abuse of Synthetic Cannabis
Davis, C., & Boddington, D. (2015) · Heart Lung and Circulation · doi:10.1016/j.hlc.2015.04.176 · Cited by 50
Grapp, M., Kaufmann, C., Streit, F., & Binder, L. (2018) · Forensic Science International · doi:10.1016/j.forsciint.2018.03.039 · Cited by 50
Koch, K., Auwärter, V., Hermanns‐Clausen, M., Wilde, M., & Neukamm, M. A. (2018) · Drug Testing and Analysis · doi:10.1002/dta.2391 · Cited by 50
Pulmonary Effects of Synthetic Marijuana: Chest Radiography and CT Findings
Berkowitz, E. A., Henry, T. S., Veeraraghavan, S., Staton, G. W., & Gal, A. A. (2014) · American Journal of Roentgenology · doi:10.2214/ajr.14.13138 · Cited by 48
Therapeutic Use of Synthetic Cannabinoids: Still an Open Issue?
Luca, M. A. D., & Fattore, L. (2018) · Clinical Therapeutics · doi:10.1016/j.clinthera.2018.08.002 · Cited by 48
Designer benzodiazepines’ pharmacological effects and potencies: How to find the information
Balkhi, S. E., Monchaud, C., Herault, F., Geniaux, H., & Saint‐Marcoux, F. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119901096 · Cited by 48
Dargan, P. I., Tang, H. C., Liang, W., Wood, D. M., & Yew, D. T. W. (2014) · Clinical Toxicology · doi:10.3109/15563650.2014.892605 · Cited by 47
Self-citationAndersson, M., & Kjellgren, A. (2017) · Nordic Studies on Alcohol and Drugs · doi:10.1177/1455072517706304 · Cited by 45
Postmortem concentrations of the synthetic opioid U-47700 in 26 fatalities associated with the drug
Fels, H., Lottner-Nau, S., Sax, T., Roider, G., Graw, M., Auwärter, V., & Mußhoff, F. (2019) · Forensic Science International · doi:10.1016/j.forsciint.2019.04.010 · Cited by 45
Helander, A., Bäckberg, M., & Beck, O. (2020) · PLoS ONE · doi:10.1371/journal.pone.0232038 · Cited by 45
Synthetic Cannabinoids and Cardiac Arrhythmia Risk: Review of the Literature
Öztürk, H. M., Yetkın, E., & Öztürk, S. (2019) · Cardiovascular Toxicology · doi:10.1007/s12012-019-09522-z · Cited by 44
A Public Health Issue: Dietary Supplements Promoted for Brain Health and Cognitive Performance
Crawford, C. C., Boyd, C. C., Avula, B., Wang, Y., Khan, I. A., & Deuster, P. A. (2020) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2019.0447 · Cited by 44
Fentanyl behind bars: The implications of synthetic opiates for prisoners and correctional officers
Bucerius, S. M., & Haggerty, K. D. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.05.018 · Cited by 43
Angoa‐Pérez, M., Zagorac, B., Winters, A. D., Greenberg, J. M., Ahmad, M. M., Theis, K. R., & Kuhn, D. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227774 · Cited by 43
Mensen, V. T., Vreeker, A., Nordgren, J., Atkinson, A. M., de la Torre, R., Farré, M., Ramaekers, J. G., & Brunt, T. M. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05238-8 · Cited by 42
Hout, M. C. V., & Hearne, E. (2016) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-016-9650-x · Cited by 41
A non-fatal intoxication and seven deaths involving the dissociative drug 3-MeO-PCP
Johansson, A., Lindstedt, D., Roman, M., Thelander, G., Nielsen, E. I., Lennborn, U., Sandler, H., Rubertsson, S., Ahlner, J., Kronstrand, R., et al. (2017) · Forensic Science International · doi:10.1016/j.forsciint.2017.02.034 · Cited by 41
Vaping Synthetic Cannabinoids: A Novel Preclinical Model of E-Cigarette Use in Mice
Lefever, T. W., Marusich, J. A., Thomas, B. F., Barrus, D. G., Peiper, N. C., Kevin, R. C., & Wiley, J. L. (2017) · Substance Abuse Research and Treatment · doi:10.1177/1178221817701739 · Cited by 41
Nóbrega, L. D. M., & Dinis‐Oliveira, R. J. (2018) · Drug Metabolism Reviews · doi:10.1080/03602532.2018.1448867 · Cited by 41
NBOMe and 2C substitute phenylethylamine exposures reported to the National Poison Data System
Srisuma, S., Bronstein, A. C., & Hoyte, C. O. (2015) · Clinical Toxicology · doi:10.3109/15563650.2015.1054502 · Cited by 40
Luethi, D., Walter, M., Zhou, X. C., Rudin, D., Krähenbühl, S., & Liechti, M. E. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00438 · Cited by 39
Synthetic cannabinoid hyperemesis resulting in rhabdomyolysis and acute renal failure
Argamany, J. R., Reveles, K. R., & Duhon, B. M. (2015) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2015.08.051 · Cited by 38
Shevyrin, V. A., Melkozerov, V. P., Endres, G. W., Shafran, Y., & Morzherin, Y. Y. (2016) · Cannabis and Cannabinoid Research · doi:10.1089/can.2016.0004 · Cited by 36
Synthetic Cannabinoid‐Associated Multiple Organ Failure: Case Series and Literature Review
Armstrong, F., McCurdy, M. T., & Heavner, M. S. (2019) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2241 · Cited by 36
Analytical Findings of an Acute Intoxication after Inhalation of Methoxetamine
Imbert, L., Boucher, A., Delhome, G., Cueto, T., Boudinaud, M., Maublanc, J., Dulaurent, S., Descotes, J., Lachâtre, G., & Gaulier, J. (2014) · Journal of Analytical Toxicology · doi:10.1093/jat/bku052 · Cited by 35
Use of new psychoactive substances to mimic prescription drugs: The trend in France
Batisse, A., Eiden, C., Peyrière, H., & Djezzar, S. (2020) · NeuroToxicology · doi:10.1016/j.neuro.2020.03.015 · Cited by 35
Case Report: Synthetic Cannabinoid Deaths in State of Florida Prisoners.
Hvozdovich, J. A., Chronister, C. W., Logan, B., & Goldberger, B. (2019) · Journal of Analytical Toxicology · doi:10.1093/jat/bkz092 · Cited by 34
Mono-/polyintoxication with 5F-ADB: A case series
Krämer, M., Fels, H., Dame, T., Mußhoff, F., Halter, S., Mogler, L., Heß, C., Madea, B., & Maas, A. (2019) · Forensic Science International · doi:10.1016/j.forsciint.2019.05.017 · Cited by 30
Kolaczynska, K. E., Luethi, D., Trachsel, D., Hoener, M. C., & Liechti, M. E. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01423 · Cited by 30
Methoxetamine affects brain processing involved in emotional response in rats
Zanda, M. T., Fadda, P., Antinori, S., Chio, M. D., Fratta, W., Chiamulera, C., & Fattore, L. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13952 · Cited by 28
Fatal case of poisoning with a new cathinone derivative: α-propylaminopentiophenone (N-PP)
Majchrzak, M., Celiński, R., Kowalska, T., & Sajewicz, M. (2018) · Forensic Toxicology · doi:10.1007/s11419-018-0417-x · Cited by 28
Nash, C., Butzbach, D. M., Stockham, P. C., Scott, T., Abroe, G., Painter, B., Gilbert, J., & Kostakis, C. (2018) · Journal of Analytical Toxicology · doi:10.1093/jat/bky099 · Cited by 28
Acute severe intoxication with cyclopropylfentanyl, a novel synthetic opioid
Wilde, M., Sommer, M. J., Auwärter, V., & Hermanns‐Clausen, M. (2019) · Toxicology Letters · doi:10.1016/j.toxlet.2019.11.025 · Cited by 28
Synthetic Cathinones and Their Potential Interactions with Prescription Drugs
Contrucci, R. R., Brunt, T. M., Inan, F., Franssen, E. J. F., & Hondebrink, L. (2019) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000682 · Cited by 27
Creagh, S. (2018) · Clinical Radiology & Imaging Journal · doi:10.23880/crij-16000116 · Cited by 25
Müller, D., Neurath, H., Neukamm, M. A., Wilde, M., Despicht, C., Blaschke, S., & Grapp, M. (2019) · Clinical Toxicology · doi:10.1080/15563650.2018.1554187 · Cited by 25
Costa, G., Porceddu, P. F., Serra, M., Casu, M. A., Schiano, V., Napolitano, F., Pinna, A., Usiello, A., & Morelli, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071556 · Cited by 25
Abiero, A., Botanas, C. J., Custodio, R. J. P., Sayson, L. V., Kim, M., Lee, H. J., Kim, H. J., Lee, K. W., Jeong, Y., Seo, J., et al. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05412-y · Cited by 25
Kamour, A. M., James, D. A., Spears, R., Cooper, G. A. A., Lupton, D. J., Eddleston, M., Thompson, J. P., Vale, A. J., Thanacoody, R. H. K., Hill, S. L., et al. (2014) · Clinical Toxicology · doi:10.3109/15563650.2014.885983 · Cited by 24
Ellsworth, J. T. (2019) · Substance Abuse · doi:10.1080/08897077.2019.1686725 · Cited by 24
Motives and Correlates of Anabolic-Androgenic Steroid Use With Stimulant Polypharmacy
Zahnow, R., McVeigh, J., Bates, G., & WINSTOCK, A. R. (2020) · Contemporary Drug Problems · doi:10.1177/0091450920919456 · Cited by 24
Dinis-Oliveira, R. J., & Magalhães, T. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030770 · Cited by 23
“Trip-Sitting” in the Black Hole: A Netnographic Study of Dissociation and Indigenous Harm Reduction
Hearne, E., & Hout, M. C. V. (2016) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2016.1207827 · Cited by 23
Yamasaki, T., Mori, W., Zhang, Y., Hatori, A., Fujinaga, M., Wakizaka, H., Kurihara, Y., Wang, L., Nengaki, N., Ohya, T., et al. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2018.05.015 · Cited by 23
Luethi, D., Widmer, R., Trachsel, D., Hoener, M. C., & Liechti, M. E. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.05.014 · Cited by 23
Endogenous opiates and behavior: 2017
Bodnar, R. J. (2019) · Peptides · doi:10.1016/j.peptides.2019.170223 · Cited by 23
Impairment of Synaptic Plasticity by Cannabis, Δ9-THC, and Synthetic Cannabinoids
Hoffman, A. F., Hwang, E.-K., & Lupica, C. R. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a039743 · Cited by 23
Franzén, L., Bäckberg, M., Beck, O., & Helander, A. (2018) · Journal of Medical Toxicology · doi:10.1007/s13181-018-0668-2 · Cited by 21
Mass poisoning with NPS: 2C-E and Bromo-DragonFly
Iwersen‐Bergmann, S., Lehmann, S., Heinemann, A. W., Schröder, C., Müller, A. F., Jungen, H., Andresen‐Streichert, H., Pueschel, K., Vidal, C., & Mercer‐Chalmers‐Bender, K. (2018) · International Journal of Legal Medicine · doi:10.1007/s00414-018-1882-9 · Cited by 20
Banister, S. D., Kevin, R. C., Martin, L. J., Adams, A. J., Macdonald, C. E., Manning, J. J., Boyd, R. A., Cunningham, M. E. A., Stevens, M. Y., McGregor, I. S., et al. (2019) · Drug Testing and Analysis · doi:10.1002/dta.2583 · Cited by 20
Kimble, A. N., & DeCaprio, A. P. (2019) · Forensic Chemistry · doi:10.1016/j.forc.2019.100189 · Cited by 20
New psychoactive substances: Pharmacology influencing UK practice, policy and the law
Nutt, D. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14209 · Cited by 20
Phenazepam: A review of medico-legal deaths in South Scotland between 2010 and 2014
Shearer, K., Bryce, C., Parsons, M., & Torrance, H. J. (2015) · Forensic Science International · doi:10.1016/j.forsciint.2015.07.033 · Cited by 19
Mistaking 2C-P for 2C-B: What a Difference a Letter Makes
Stoller, A., Dolder, P. C., Bodmer, M., Hammann, F., Rentsch, K., Exadaktylos, A. K., Liechti, M. E., & Liakoni, E. (2016) · Journal of Analytical Toxicology · doi:10.1093/jat/bkw108 · Cited by 19
Understanding the UK Psychoactive Substances Act
Hill, R. G. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14168 · Cited by 19
Kriikku, P., Pelander, A., Rasanen, I., & Ojanperä, I. A. (2019) · Forensic Science International · doi:10.1016/j.forsciint.2019.04.030 · Cited by 18
Nia, A. B., Mann, C. L., Spriggs, S. A., DeFrancisco, D., Carbonaro, S., Parvez, L., GALYNKER, I. I., Perkel, C., & Hurd, Y. L. (2019) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.18m12539 · Cited by 17
Psychoactive Bath Salts and Neurotoxicity Risk
Altun, B., & Çok, İ. (2020) · Turkish Journal of Pharmaceutical Sciences · doi:10.4274/tjps.galenos.2018.40820 · Cited by 17
Novel Psychoactive Substances: Classification and General Information
Zawilska, J. B., & Wojcieszak, J. (2018) · Current topics in neurotoxicity · doi:10.1007/978-3-319-78707-7_2 · Cited by 15
Synthetic Cathinones: Neurotoxic Health Hazards and Potential for Abuse
Archer, T., & Kostrzewa, R. M. (2018) · Current topics in neurotoxicity · doi:10.1007/978-3-319-78707-7_1 · Cited by 13
Ren, B., Suriawinata, A. A., & Iwai, M. (2019) · Springer eBooks · doi:10.1007/978-981-13-6806-6_8 · Cited by 13
McAuley, A., Yeung, A., Taylor, A., Hutchinson, S. J., Goldberg, D. J., & Munro, A. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.01.008 · Cited by 12
Clinical Manual of Youth Addictive Disorders
(2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615372812 · Cited by 10
Methoxetamine: A foe or friend?
Botanas, C. J., de la Peña, J. B., Kim, H. J., Lee, Y. S., & Cheong, J. H. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.10.020 · Cited by 9
Cultures of Intoxication: ‘New’ Psychoactive Substances
Hutton, F. (2020) · Springer eBooks · doi:10.1007/978-3-030-35284-4_5 · Cited by 8
Pulmonary embolism due to synthetic cannabinoid use: Case report
Yırgın, G. (2018) · Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology · doi:10.5543/tkda.2018.84425 · Cited by 7
Takeda, A., Doi, T., Asada, A., Suzuki, T., Yuzawa, K., Ando, H., Kubo, Y., Nagasawa, A., Kaihoko, F., Hasegawa, Y., et al. (2020) · Forensic Toxicology · doi:10.1007/s11419-020-00534-x · Cited by 7
AYDIN, G., & Bakar, B. (2019) · Bulletin of Emergency and Trauma · doi:10.29252/beat-0703019 · Cited by 6
Ojeda, A. A. A., Murtaza, S., Shah, A. A., & Moukaddam, N. J. (2018) · Psychiatric Annals · doi:10.3928/00485713-20180719-02 · Cited by 2
Management of Acute Substance Use Disorders: Hallucinogens and Associated Compounds
Nisavic, M., & Lai-Becker, M. W. (2019) · Current clinical psychiatry · doi:10.1007/978-3-319-23961-3_5 · Cited by 2
MARCH, R. J., Guentert, P., Kloska-Kearney, E., Kwak, D., Yerger, C., McBride, M., Majewski, J. R., McCauley, R. D., Hatch, J. B., Speybroeck, J., et al. (2020) · International Journal of Clinical Medicine · doi:10.4236/ijcm.2020.112006 · Cited by 2
Cited by
Mikulska, J., Juszczyk, G., Gawrońska-Grzywacz, M., & Herbet, M. (2021) · Brain Sciences · doi:10.3390/brainsci11101298 · Cited by 450
Non-Fentanyl New Synthetic Opioids—An Update
Zawilska, J. B., Adamowicz, P., Kurpeta, M., & Wojcieszak, J. (2023) · Forensic Science International · doi:10.1016/j.forsciint.2023.111775 · Cited by 55
Acute drug poisonings leading to hospitalization
Andersen, C. U., Nielsen, L. P., Møller, J. M., & Olesen, A. E. (2022) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13688 · Cited by 11
Nalakath, J., Thacholil, R. P., Kadry, A., P, S., & Praseen, O. K. (2025) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.9982 · Cited by 6
Metadata
- Authors
- Shafi, A., Berry, A. J., Sumnall, H., Wood, D. M., & Tracy, D. K.
- Venue
- Therapeutic Advances in Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2020-01
- Volume
- 10
- Pages
- 2045125320967197-2045125320967197
- ISSN
- 2045-1253 (ISSN-L)
- 2045-1261
- OpenAlex
- W3112564761
- Cited by
- 347
- References
- 186
- FWCI
- 64.38
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.